SANGAMO THERAPEUTICS, INC (CIK 1001233, SGMOQ) reported 5 filings on its bankruptcy or receivership to the SEC on Form 8-K under Item 1.03, the latest filed 2026-09-21. It gives its business address as Richmond, California. Its registered industry is Biological Products, (No Diagnostic Substances). The sentences below are quoted from the filings as written.
The filings
Form 8-K filed 2026-09-21
This filing reports Item 1.03 and states none of the petition, chapter, court or case in a single sentence. The full text is in the filing.
Form 8-K filed 2026-09-08
This filing reports Item 1.03 and states none of the petition, chapter, court or case in a single sentence. The full text is in the filing.
Form 8-K filed 2026-08-28 · Chapter 11
The petition
As previously announced, on June 23, 2026, Sangamo Therapeutics, Inc. (the "Company") filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"), thereby commencing a Chapter 11 case for the Company (the "Chapter 11 Case").
Case
The case number is 26-10989 and the Chapter 11 Case is styled as In re Sangamo Therapeutics , Inc .
Form 8-K filed 2026-07-20 · Chapter 11
The petition
As previously disclosed, on June 23, 2026 (the "Petition Date"), Sangamo Therapeutics, Inc. (the "Company") filed a voluntary petition (Case No. 26-10989) for relief under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (such court, the "Court" and such case, the "Case").
Form 8-K filed 2026-06-23 · Chapter 11
The petition
On June 23, 2026 (the "Petition Date"), Sangamo Therapeutics, Inc. (the "Company") filed a voluntary petition (Case No. 26-10989) for relief under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (such court, the "Court" and such case, the "Case").
Where this comes from
Public companies report a bankruptcy, a receivership or a similar proceeding to the SEC on Form 8-K under Item 1.03, usually within four business days. Every filing listed here is one of them, linked to the filing itself. The sentences shown are quoted from the filing exactly; where a filing does not state the court, the case or the chapter in one sentence, nothing is shown in its place.
The state is where the company says its business is, and the industry is the one it registered with the SEC. A filing reports what the company filed; it does not say whether creditors will be paid, and neither does this page.
All recent bankruptcy filingsThat week
Cite this page
https://mentionfox.com/bankruptcy/sangamo-therapeutics